These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 12041546)
1. Partial purification of mitochondrial DNA topoisomerase II from Plasmodium falciparum and its sensitivity to inhibitors. Chavalitshewinkoon-Petmitr P; Worasing R; Wilairat P Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):733-8. PubMed ID: 12041546 [TBL] [Abstract][Full Text] [Related]
2. Partial purification and characterization of DNA topoisomerase II from Plasmodium falciparum. Chavalitshewinkoon P; Leelaphiwat S; Wilairat P Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):32-6. PubMed ID: 7825022 [TBL] [Abstract][Full Text] [Related]
3. Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum. Auparakkitanon S; Wilairat P Biochem Biophys Res Commun; 2000 Mar; 269(2):406-9. PubMed ID: 10708566 [TBL] [Abstract][Full Text] [Related]
4. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors. Petmitr PC; Ramdja M; Kajorndechakiat S Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):118-22. PubMed ID: 11023077 [TBL] [Abstract][Full Text] [Related]
5. Partial purification and characterization of Trichomonas vaginalis DNA topoisomerase II. Sithiprom S; Petmitr S; Chavalitshewinkoon-Petmitr P Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):877-85. PubMed ID: 19842367 [TBL] [Abstract][Full Text] [Related]
6. Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum. Weissig V; Vetro-Widenhouse TS; Rowe TC DNA Cell Biol; 1997 Dec; 16(12):1483-92. PubMed ID: 9428797 [TBL] [Abstract][Full Text] [Related]
7. Active DNA topoisomerase II with minimum molecular mass from regenerating rat liver. Park SH; Lee CG; Namkung R; Kim CG; Park SD Biochem Mol Biol Int; 1994 Mar; 32(4):641-50. PubMed ID: 8038715 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial NADH dehydrogenase from Plasmodium falciparum and Plasmodium berghei. Krungkrai J; Kanchanarithisak R; Krungkrai SR; Rochanakij S Exp Parasitol; 2002 Jan; 100(1):54-61. PubMed ID: 11971654 [TBL] [Abstract][Full Text] [Related]
9. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA. Lin JH; Castora FJ Arch Biochem Biophys; 1995 Dec; 324(2):293-9. PubMed ID: 8554321 [TBL] [Abstract][Full Text] [Related]
10. Expression, purification and characterization of recombinant mitochondrial topoisomerase II of kinetoplastid Crithidia fasciculata in High-five insect cells. Wang Y; Tsai YC; Urena-Rivera E; Chen J Protein Expr Purif; 2008 Mar; 58(1):122-31. PubMed ID: 18068376 [TBL] [Abstract][Full Text] [Related]
11. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity. Jain P; Nagaraja V Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624 [TBL] [Abstract][Full Text] [Related]
12. Anucleate cell blue assay: a useful tool for identifying novel type II topoisomerase inhibitors. Oyamada Y; Ito H; Fujimoto-Nakamura M; Tanitame A; Iwai N; Nagai K; Yamagishi J; Wachi M Antimicrob Agents Chemother; 2006 Jan; 50(1):348-50. PubMed ID: 16377708 [TBL] [Abstract][Full Text] [Related]
13. Design of two etoposide-amsacrine conjugates: topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity. Arimondo P; Boukarim C; Bailly C; Dauzonne D; Monneret C Anticancer Drug Des; 2000 Dec; 15(6):413-21. PubMed ID: 11716434 [TBL] [Abstract][Full Text] [Related]
14. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome. Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647 [TBL] [Abstract][Full Text] [Related]
15. Quantitative adaptation of the bacteriophage P4 DNA unknotting assay for use in the biochemical and pharmacological characterization of topoisomerase II. Hofmann GA; Mirabelli CK; Drake FH Anticancer Drug Des; 1990 Aug; 5(3):273-82. PubMed ID: 2169250 [TBL] [Abstract][Full Text] [Related]
16. Partial purification and characterization of mitochondrial DNA polymerase from Plasmodium falciparum. Chavalitshewinkoon-Petmitr P; Chawprom S; Naesens L; Balzarini J; Wilairat P Parasitol Int; 2000 Dec; 49(4):279-88. PubMed ID: 11077262 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles. Föger F; Noonpakdee W; Loretz B; Joojuntr S; Salvenmoser W; Thaler M; Bernkop-Schnürch A Int J Pharm; 2006 Aug; 319(1-2):139-46. PubMed ID: 16713146 [TBL] [Abstract][Full Text] [Related]
18. Partial purification and characterization of DNA polymerase beta-like enzyme from Plasmodium falciparum. Nunthawarasilp P; Petmitr S; Chavalitshewinkoon-Petmitr P Mol Biochem Parasitol; 2007 Aug; 154(2):141-7. PubMed ID: 17540464 [TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a mouse FM3A cell mutant resistant to topoisomerase II-inhibitor NC-190. Samata K; Yamagishi T; Ichihara T; Nanaumi K; Ikeda T; Ikeya H; Kuraishi A; Nakaike S; Kashiwagi K; Igarashi K Cancer Chemother Pharmacol; 2002 Nov; 50(5):367-72. PubMed ID: 12439594 [TBL] [Abstract][Full Text] [Related]
20. Expression and characterization of the ATP-binding domain of a malarial Plasmodium vivax gene homologous to the B-subunit of the bacterial topoisomerase DNA gyrase. Khor V; Yowell C; Dame JB; Rowe TC Mol Biochem Parasitol; 2005 Mar; 140(1):107-17. PubMed ID: 15694492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]